CNS-DLBCL could be perfectly differentiated from antibody-negative ALE patients (AUC of 1.0) with CSF CD4+HLADR+, CSF CD8+HLADR, and QAlb being the most important parameters (Fig. 3D). The gene discussed is CD8A; the disease is diffuse large B-cell lymphoma.